Kwality Pharmaceuticals Ltd · NSE:KPL

Kwality Pharmaceuticals Ltd financial statements

Kwality Pharmaceuticals Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023
Revenue5.03B3.70B3.07B2.51B
Cost of revenue2.61B1.87B1.63B1.19B
Gross profit2.42B1.83B1.44B1.32B
Selling, general and administrative253.3M227.2M125.7M190.8M
Operating income984.5M621.0M467.9M457.7M
Depreciation and amortization198.1M182.9M195.6M149.6M
EBITDA1.18B803.9M663.5M607.3M
Interest expense109.7M98.8M103.9M60.2M
Income before tax894.9M541.4M311.0M255.7M
Net income673.5M398.5M238.0M193.7M
Earnings per share, basic64.9038.4022.9318.67

Balance sheet

LineFY2026FY2025FY2024FY2023
Cash and equivalents7.36M120.2M22.6M30.7M
Short-term investments28.6M27.4M36.9M42.9M
Receivables2.80B1.54B1.14B716.9M
Inventory782.5M834.7M783.9M863.1M
Current assets4.06B2.84B2.43B2.07B
Total assets5.92B4.47B3.94B3.54B
Accounts payable1.02B557.9M443.2M351.9M
Current liabilities2.26B1.70B1.52B1.26B
Long-term debt294.0M151.2M195.6M273.0M
Total liabilities2.62B1.85B1.72B1.55B
Shareholders' equity3.32B2.64B2.24B2.01B
Shares outstanding10.4M10.4M10.4M10.4M

Cash flow

LineFY2026FY2025FY2024FY2023
Cash from operations165.9M527.2M429.8M413.8M
Capital spending-489.4M-250.0M-298.4M-476.7M
Free cash flow-323.5M277.2M131.4M-62.9M
Change in cash-112.8M97.6M-8.12M-60.6M